CVE-2020-3207

Cisco IOS XE Software Command Injection Vulnerability

Description

A vulnerability in the processing of boot options of specific Cisco IOS XE Software switches could allow an authenticated, local attacker with root shell access to the underlying operating system (OS) to conduct a command injection attack during device boot. This vulnerability is due to insufficient input validation checks while processing boot options. An attacker could exploit this vulnerability by modifying device boot options to execute attacker-provided code. A successful exploit may allow an attacker to bypass the Secure Boot process and execute malicious code on an affected device with root-level privileges.

Categories

6.7
CVSS
Severity: Medium
CVSS 3.1 •
CVSS 3.0 •
CVSS 2.0 •
EPSS 0.21%
Vendor Advisory cisco.com
Affected: Cisco Cisco IOS XE Software 16.9.2
Published at:
Updated at:

References

Frequently Asked Questions

What is the severity of CVE-2020-3207?
CVE-2020-3207 has been scored as a medium severity vulnerability.
How to fix CVE-2020-3207?
To fix CVE-2020-3207, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2020-3207 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2020-3207 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2020-3207?
CVE-2020-3207 affects Cisco Cisco IOS XE Software 16.9.2.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.